The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Adams R Mark since 2021.
This trader's CIK number is 1808905.
At the time of last reporting, Adams R Mark was the Chief Operating Officer of Adaptive Biotechnologies Corp. (stock ticker symbol ADPT).
Also see all insider trading activities at Adaptive Biotechnologies Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ADPT | 0 | $0 | 29,934 | $257,080 | 0 | $0 |
| 2022 | ADPT | 0 | $0 | 9,346 | $104,320 | 0 | $0 |
| 2021 | ADPT | 0 | $0 | 33,333 | $1,300,529 | 14,583 | $409,782 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-10 | ADPT | Sale | 817 | 8.50 | 6,944 |
| 2023-04-11 | ADPT | Sale | 2,308 | 8.63 | 19,918 |
| 2023-03-06 | ADPT | Sale | 6,529 | 8.57 | 55,953 |
| 2023-03-07 | ADPT | Sale | 17,155 | 8.60 | 147,533 |
| 2023-01-10 | ADPT | Sale | 2,130 | 8.58 | 18,275 |
| 2023-01-09 | ADPT | Sale | 995 | 8.50 | 8,457 |
| 2022-10-07 | ADPT | Sale | 841 | 7.61 | 6,400 |
| 2022-10-10 | ADPT | Sale | 2,284 | 7.13 | 16,284 |
| 2022-07-07 | ADPT | Sale | 825 | 9.53 | 7,862 |
| 2022-07-08 | ADPT | Sale | 2,300 | 10.47 | 24,081 |
| 2022-04-07 | ADPT | Sale | 831 | 13.17 | 10,944 |
| 2022-03-07 | ADPT | Sale | 1,244 | 12.01 | 14,940 |
| 2022-01-07 | ADPT | Sale | 1,021 | 23.32 | 23,809 |
| 2021-10-07 | ADPT | Sale | 1,324 | 32.47 | 42,990 |
| 2021-10-08 | ADPT | Sale | 1,801 | 33.67 | 60,639 |
| 2021-07-08 | ADPT | Sale | 2,254 | 36.30 | 81,820 |
| 2021-07-07 | ADPT | Sale | 871 | 39.42 | 34,334 |
| 2021-06-17 | ADPT | Option Ex | 14,583 | 28.10 | 409,782 |
| 2021-06-17 | ADPT | Sale | 14,583 | 40.00 | 583,320 |
| 2021-06-14 | ADPT | Sale | 8,914 | 38.77 | 345,595 |
| 2021-04-07 | ADPT | Sale | 3,586 | 42.34 | 151,831 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adams R Mark (Chief Operating Officer of Adaptive Biotechnologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.